1. SOUND ANALYSIS OF MOLECULAR
CONNECTION COMPANY TO ENTER
INTO THE MARKET USA
2. Introduction
• This presentation will discuss the strategy and analysis of Molecular
Connection (MC) Company along with the comparison of the market of the
USA and India
• MC is recognized as the leading technology-driven organization dealing with
content operations
• The company leverages machine learning and artificial technologies
• This study includes the analysis of the company’s shared goals, strategies,
and different environmental aspects along with the recommended market
entry modes
3. Discussion of the company’s strategy
SWOT analysis
Strengths
Extensive expertise: MC employs significant experts and skilled
professionals
Successful track record: Repeat business success with a higher
technology implementation success rate
(Molecularconnections.com, 2023)
Weaknesses
Technology dependency: The company is heavily relying on the
ML and AI technologies
Niche Market: MC’s primary focus depends on life science
innovation limiting its diversification
Opportunities
Significant market expansion: MC is continuously exploring
opportunities in other industries beyond life science
Increasing global reach: MC’s delivery model is based on agile
location-independent strategies
Threats
Competitive marketplace: It is facing intensive competition from
other companies operating in content operations.
Rapid advancement in technology: It has been complicated to
stay updated on rapid changes in technological advancement.
4. Company’s vision, mission, and values
• Vision: To pioneer in developing the structure of different unstructured data and help
the customer to take significant actions
• Mission: To enable the client organization’s digital transformation across different
business domains by leveraging (Molecularconnections.com, 2023)
• Values: The Company focuses on its client’s expectations and needs to drive their
actions with excellence. Moreover, the organization’s values are depended on the
ethics, accountability, and quality of its services.
5. Evaluation of previous entry modes
• The company has initiated acquisition and merger strategies to expand
its market share in 2014
• It has followed a buyback program from a major venture capitalist
organization
• Through balanced, creative, and precise modes of entry, the company
sustains its operational market (Kar and Dwivedi, 2020)
• The company has established two significant subsidiaries companies
6. Macro-environmental aspects in the USA
PESTLE analysis
• Political factors: Different government policies related to intellectual property, data privacy (GDPR
laws), and technology implementation
• Economic Factors: Fluctuation in currency exchange rate affects the demands for data analytics and
content operation services (Van Doorn and Badger, 2020)
• Sociocultural factors: Increasing demand for personalized content, cultural nuances, and diverse
preferences of the consumers affect its business operations in the market of the USA.
• Technological Factors: Cyber security concerns, and rapid advancement process in AI and ML
technologies affect its operation (Himanen et al., 2019)
• Legal Factors: Compliance with the HIPAA regulations for the data analytics of healthcare data
• Environmental Factors: Cloud-based data storage solutions can reduce the environmental impacts on
technology infrastructures and data centers minimizing the consumption of energy
7. Social demographic trends
• Gen Z and Millennial consumers are demanding
more personalized experiences in content operations
(Huang and Rust, 2021)
• Aging and elderly populations seek personalized
content and significant health information
• Enhanced connectivity and digital literacy of the
consumers demand effective content on their mobile
devices (Sarker, 2021)
• Wellness and Health trends based on the fitness,
nutrition, mental health, and well-being of the
people demand personalized tips and preventive
measure
8. Regulatory and political systems
• IP protection laws and FDA regulations should be
followed by molecular connection
• The USA’s support for genetic engineering and
biotechnology could be leveraged by the
company
• Global consumer data protection laws like GDPR
and CCPA are to comply with the organization’s
operations (Akter et al., 2021)
• The company has to engage with different
industry associations and advocacy groups like
TechNet, and ITAA
9. Financial and economic conditions
• The market of healthcare analytics in the USA is growing significantly
(Mordorintelligence.com, 2023)
• The government grants, angel investors, and venture capitalists could
make significant investments in the industry (Soni et al., 2020)
• Post-pandemic impact and recovery process could impact its business
spending
• It is significant to align with the strategies of the economic cycle to
navigate through the economic recovery process from the pandemic
10. Competitive dynamics within the
industry
• The data analytics and content operation sector in the USA is highly
competitive
• Different companies like Agilent Technologies, Abbott Laboratories,
Hologic Corporation, and Danaher Corporation are operating in the market
• “Next-generation sequencing (NGS)” and “Point of care (POC) diagnostic”
could be a significant competitive advantage (Finlay, 2021)
• Strategic collaboration and partnership with different pharmaceutical
companies, hospitals, and research institutions could enhance its market
presence
11. Porter’s Five Force Model
• Intense rivalries among the existing competitors including Hologic
Corporation, Abbott Laboratories, and Agilent Technologies
• New entrant’s threat can affect the company’s profitability (Gerke et al.,
2020)
• Changing preferences and expectations from consumers could influence
the market demand and pricing for content operations
• Suppliers could have the power to influence the quality and costs of the
raw information and technologies (Balakrishnan and Dwivedi, 2021)
• Substitute products and services could negatively impact the MC’s
services
12. Analysis of new entrants
• With significant potential for growth within this industry, new
entrants could disrupt the market by offering innovative solutions
• New market players could target the niche segments and leverage
emerging technological trends (Benjamens et al., 2020)
• The need for personalized information and molecular diagnostic
demand could be opportunities for new entrants
• The common barriers include complexity in content operations,
leveraging effective technological solutions, and huge investments
13. Industry’s competitive nature
• The competitiveness in the industry is driven by
increasing demand for customized healthcare
options, the need for rapid diagnosis, and
technological advancement
• Monitoring of data-driven insights and effective
analytics of the industry trends could set the
company apart from the competitive marketplace
(Hagerty and Rubinov, 2019)
• Handling robust data about patients’ diagnoses and
population demographics could be challenging
• It is significant to understand the needs of the clients
and provide exceptional information services
fostering the loyalty of the customers
14. Strategic recommendations
Effective entry modes
• It is crucial to choose the appropriate entry mode
• By considering the competitive industry landscape in the USA, MC should
follow the mode of “licensing” to expand its business operation in the
market USA
• It could provide a license to local partnered organizations in the USA for its
proprietary business model including its content analytics algorithms
(Mariani et al., 2022)
• By implementing this mode, the company could use its intellectual property
to provide effective data-driven insights, content solutions, and actionable
information (Lee and Yoon, 2021)
15. Alignment with the company’s
services
• The licensing could be provided based on its effective analytics
tools
• It could be given to local research institutions, healthcare
providers, or pharmacy companies
• The algorithms of the ML program could be shared with its
partnered organization effectively (Birch et al., 2020)
• Diagnostic algorithms and AI-driven information are used to
allow the local labs in the USA
16. Alignment with the company’s
mission and goals
• It is crucial to choose the appropriate entry mode
• By considering the competitive industry landscape in the USA, MC should
follow the mode of “licensing” to expand its business operation in the
market USA
• It could provide a license to local partnered organizations in the USA for its
proprietary business model including its content analytics algorithms
(Mariani et al., 2022)
• By implementing this mode, the company could use its intellectual property
to provide effective data-driven insights, content solutions, and actionable
information (Lee and Yoon, 2021)
17. Strategic recommendations
Effective entry modes
• It is crucial to choose the appropriate entry mode
• By considering the competitive industry landscape in the USA, MC should
follow the mode of “licensing” to expand its business operation in the
market USA
• It could provide a license to local partnered organizations in the USA for its
proprietary business model including its content analytics algorithms
(Mariani et al., 2022)
• By implementing this mode, the company could use its intellectual property
to provide effective data-driven insights, content solutions, and actionable
information (Lee and Yoon, 2021)
18. Strategic recommendations
Effective entry modes
• It is crucial to choose the appropriate entry mode
• By considering the competitive industry landscape in the USA, MC should
follow the mode of “licensing” to expand its business operation in the
market USA
• It could provide a license to local partnered organizations in the USA for its
proprietary business model including its content analytics algorithms
(Mariani et al., 2022)
• By implementing this mode, the company could use its intellectual property
to provide effective data-driven insights, content solutions, and actionable
information (Lee and Yoon, 2021)
19. Strategic recommendations
Effective entry modes
• It is crucial to choose the appropriate entry mode
• By considering the competitive industry landscape in the USA, MC should
follow the mode of “licensing” to expand its business operation in the
market USA
• It could provide a license to local partnered organizations in the USA for its
proprietary business model including its content analytics algorithms
(Mariani et al., 2022)
• By implementing this mode, the company could use its intellectual property
to provide effective data-driven insights, content solutions, and actionable
information (Lee and Yoon, 2021)
20. Strategic recommendations
Effective entry modes
• It is crucial to choose the appropriate entry mode
• By considering the competitive industry landscape in the USA, MC should
follow the mode of “licensing” to expand its business operation in the
market USA
• It could provide a license to local partnered organizations in the USA for its
proprietary business model including its content analytics algorithms
(Mariani et al., 2022)
• By implementing this mode, the company could use its intellectual property
to provide effective data-driven insights, content solutions, and actionable
information (Lee and Yoon, 2021)
21. Reference List
• Adepu, S. and Ramakrishna, S., 2021. Controlled drug delivery systems: current status and future directions. Molecules,
26(19), p.5905.
• Akhtar, N., Singh, V., Yusuf, M. and Khan, R.A., 2020. Non-invasive drug delivery technology: Development and current
status of transdermal drug delivery devices, techniques and biomedical applications. Biomedical
Engineering/Biomedizinische Technik, 65(3), pp.243-272.
• Chauhan, I., Yasir, M., Verma, M. and Singh, A.P., 2020. Nanostructured lipid carriers: A groundbreaking approach for
transdermal drug delivery. Advanced pharmaceutical bulletin, 10(2), p.150.
• Jeong, W.Y., Kwon, M., Choi, H.E. and Kim, K.S., 2021. Recent advances in transdermal drug delivery systems: A review.
Biomaterials research, 25, pp.1-15.
• Keservani, R.K., Bandopadhyay, S., Bandyopadhyay, N. and Sharma, A.K., 2020. Design and fabrication of transdermal/skin
drug-delivery system. In Drug Delivery Systems (pp. 131-178). Academic Press.
• Kolimi, P., Narala, S., Youssef, A.A.A., Nyavanandi, D. and Dudhipala, N., 2023. A systemic review on development of
mesoporous nanoparticles as a vehicle for transdermal drug delivery. Nanotheranostics, 7(1), p.70.
• Malvey, S., Rao, J.V. and Arumugam, K.M., 2019. Transdermal drug delivery system: A mini review. Pharma Innov, 8,
pp.181-97.
• Matharoo, N., Mohd, H. and Michniak‐Kohn, B., 2023. Transferosomes as a transdermal drug delivery system: Dermal
kinetics and recent developments. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, p.e1918.
• Parmar, P.K., Wadhawan, J. and Bansal, A.K., 2021. Pharmaceutical nanocrystals: A promising approach for improved topical
drug delivery. Drug Discovery Today, 26(10), pp.2329-2349.
• Parra, A., Jarak, I., Santos, A., Veiga, F. and Figueiras, A., 2021. Polymeric micelles: A promising pathway for dermal drug
delivery. Materials, 14(23), p.7278.
• Pires, P.C., Mascarenhas-Melo, F., Pedrosa, K., Lopes, D., Lopes, J., Macário-Soares, A., Peixoto, D., Giram, P.S., Veiga, F.
and Paiva-Santos, A.C., 2023. Polymer-based biomaterials for pharmaceutical and biomedical applications: A focus on topical
drug administration. European Polymer Journal, p.111868.
• Yang, Q., Zhong, W., Xu, L., Li, H., Yan, Q., She, Y. and Yang, G., 2021. Recent progress of 3D-printed microneedles for
transdermal drug delivery. International Journal of Pharmaceutics, 593, p.120106.
This slide introduces the objectives of this study for analyzing different environmental factors and strategies for Molecular Connection which is utilizing the AI-powered models of proprietorships for helping its customers in achieving their targets of digital transformation. The company has been operating for more than two decades with significant experience in information science. It provides effective solutions to its customers which are curated and managed by different technology leaders and subject-matter experts. The company has developed different successful data-driven decision-making ideas and strategies for their customers to help them in their journey of digital transformation. MC’s solutions are effective in accelerating the discoverability of its targeted contents, empowering innovation in the subject of life science, conceiving new ideas about the products, and enabling the prototypes of new technologies with a significant success rate.
This slide provides significant insights about the company and its significant strategies in the marketplace along with its potential business threats and opportunities in the marketplace. The SWOT table has provided MC’s significant strengths, weaknesses, threats, and opportunities in the current marketplace. It has employed significant skilled employees and experts from the global talent pool enabling its effective business operations in a technology-driven decision-making process. However, the company’s limited market niche in life science and its reliance on technology implications limit its worldwide market operations.
MC Company envisions an effective world where the insights about data-driven technologies have been empowering the management to drive innovation, make informed decisions, and transform the corresponding organizations. The company strives to be the pioneer in bridging the significant gap between actionable data and raw information by structuring unstructured data. The company aims to simplify the complexity and complications in the business processes by utilizing new cutting-edge technologies. The management is committed to providing relevant, accessible, and more curated content through effective scientific study and research to its clients enabling their digital transformation at their business workplace. Moreover, the company gives value to its quality, accountability, excellence, and ethics in its services.
The entry modes of the company are considered through a detailed analysis of the MC’s various financial transactions including its investments and buybacks from various VC firms and any acquisition or merger of the company. It has established two subsidiaries including “Molecular Connections Research Pvt. Ltd. (MCPRL)” and “Molecular Connections Analytics Pvt. Ltd. (MCAPL)”. The company’s significant approaches based on its rich base of knowledge, literature study, and technology-enabled research programs have enabled it to make strategic investments in various business domains expanding its market operation.
By analyzing different PESTEL factors about the MC Company focusing on its expansion strategies in the USA, different macro-environmental factors could be understood significantly. It would help the organization gain significant insights into the country’s relevant data protection and data privacy laws, the economic circumstances of the country, and the consumer’s demands in the marketplace. Moreover, this analysis would help the organization to develop effective AI algorithms for the analysis of their client’s sentiments in social media content and regulatory frameworks for adhering to industry-specific regulations.
By exploring various socio-demographic trends in the USA’s market, the impact of these trends on the organization could effectively be understood. As the new generation of people and organizations are natives in this digital age, they expect to get significant content on the health and wellness benefits and the organization should leverage their AI and ML technology solutions to resonate with their expectations and preferences. The company should utilize different digital platforms and social media to increase its global reach by publishing various content related to its sustainable initiatives, sustainable content solutions, and health analytics.
The political and regulatory landscapes in the USA are significant aspects to consider in the expansion strategies for the company. There are different regulatory perspectives in the country including the USA’s robust laws in intellectual property, FDA regulations, and healthcare data analytics. These laws and strong regulatory frameworks in the country could help the organization protect its content solutions, proprietary algorithms, medical software, and devices. Moreover, consumer privacy and protection acts like CCPA and GDPR laws have significant impacts on the company’s operations within the country.
In the dynamic market of information and data analytics in the USA, the company has to navigate through different adverse financial landscape. The estimated market size of this industry is about $11.91 billion in 2023 and the projected market size has been estimated to reach $18.51 billion by the year 2028 with a significant rate of CAGR of 9.22%. There are significant market players within the industry operating effectively in the market increasing the competition. However, the pandemic has played a significant role in the declining demand for healthcare analytics services in the industry. The company should leverage with different cutting-edge solutions like mass spectrometry, PCR, and sequencing for their efficient services in data analytics by capitalizing on its advancements in technology and adapting to the changing dynamics in the sector.
In the competitive business landscape, the company should take significant strategies in developing its technologies, customer-centric approaches, data security measures, and strategic collaborations to gain competitive advantages. It must innovate, adapt, and collaborate significantly to thrive in the competitive landscape. It needs to tailor the analytic process effectively to draw data-driven insights about the particular disease offering personalized information to the consumers. Moreover, the competitors of the company are investing in development, research, and strategic partnerships with significant organizations. MC can differentiate their offerings through collaborating with the technology firms, and diagnostic players in the market.
Porter’s model consisting of five significant forces to enter into a new marketplace provides an effective framework for evaluating the market environment within the industry. This model has significantly helped organizations to gain insights into the significant forces that could shape the demands, prices, costs, and profitability of the services within the industry determining the organization’s weaknesses and strengths. The company should diversify its supply chains to avoid the bargaining power of the suppliers.
By leveraging new technologies like ML, AI, NGS, and POC diagnostics, the new entrants could throw significant challenges to existing companies like Roche, Abbott, and Danaher. However, the requirement of regulatory compliances, complex technology implementation, and specialized expertise could be significant barriers for the new entrants limiting their business growth within the industry. The threats from these new entrants are relevant in the USA’s market and the existing companies should take proactive approaches and strategies to fulfill the consumer’s demands and expectations.
As the industry of content operations in life science within the USA is highly competitive, the company should implement different differentiation and unique strategies to take competitive gains. With the increasing demand for customized healthcare services and rapid diagnosis, the utilization of effective ML and AI instruments could set them apart from this competitive landscape. The company should invest a significant amount in making adjustments to recent technology development, research, and analytical approaches to maintain its competitive edge.
The licensing mode of entry has been suggested for the company to make expansion to its content operations throughout the USA. It could help the management to lower its initial costs for the establishment of content operations providing effective technology-based solutions through different local organizations. Moreover, it demonstrates the significant gain of market access across the marketplace enhancing its brand recognition in the country. The company could avoid the complexities of the administrative and legal policies in the USA. Associated risks with the content operations would be significantly low as the partnered organizations would be more responsible for increasing their market share in the USA.
With the license for utilizing MC’s AI-driven technologies and data analytics processes, local organizations including pharmaceutical companies, diagnosis centers, and healthcare providers could be able to provide cutting-edge solutions for its consumers and people enhancing the impression of the MC Company. However, the company needs to ensure the consistent quality of the licensed services safeguarding its data models and algorithms through the USA’s strong IP protection laws.
The licensing mode of entry has been suggested for the company to make expansion to its content operations throughout the USA. It could help the management to lower its initial costs for the establishment of content operations providing effective technology-based solutions through different local organizations. Moreover, it demonstrates the significant gain of market access across the marketplace enhancing its brand recognition in the country. The company could avoid the complexities of the administrative and legal policies in the USA. Associated risks with the content operations would be significantly low as the partnered organizations would be more responsible for increasing their market share in the USA.
The licensing mode of entry has been suggested for the company to make expansion to its content operations throughout the USA. It could help the management to lower its initial costs for the establishment of content operations providing effective technology-based solutions through different local organizations. Moreover, it demonstrates the significant gain of market access across the marketplace enhancing its brand recognition in the country. The company could avoid the complexities of the administrative and legal policies in the USA. Associated risks with the content operations would be significantly low as the partnered organizations would be more responsible for increasing their market share in the USA.
The licensing mode of entry has been suggested for the company to make expansion to its content operations throughout the USA. It could help the management to lower its initial costs for the establishment of content operations providing effective technology-based solutions through different local organizations. Moreover, it demonstrates the significant gain of market access across the marketplace enhancing its brand recognition in the country. The company could avoid the complexities of the administrative and legal policies in the USA. Associated risks with the content operations would be significantly low as the partnered organizations would be more responsible for increasing their market share in the USA.
The licensing mode of entry has been suggested for the company to make expansion to its content operations throughout the USA. It could help the management to lower its initial costs for the establishment of content operations providing effective technology-based solutions through different local organizations. Moreover, it demonstrates the significant gain of market access across the marketplace enhancing its brand recognition in the country. The company could avoid the complexities of the administrative and legal policies in the USA. Associated risks with the content operations would be significantly low as the partnered organizations would be more responsible for increasing their market share in the USA.
The licensing mode of entry has been suggested for the company to make expansion to its content operations throughout the USA. It could help the management to lower its initial costs for the establishment of content operations providing effective technology-based solutions through different local organizations. Moreover, it demonstrates the significant gain of market access across the marketplace enhancing its brand recognition in the country. The company could avoid the complexities of the administrative and legal policies in the USA. Associated risks with the content operations would be significantly low as the partnered organizations would be more responsible for increasing their market share in the USA.